重症监护室输血实践:一项前瞻性观察性双国研究
该前瞻性、多中心、双国观察性研究于2021年10月至2022年7月在40个澳大利亚和新西兰ICU开展,纳入所有成人(≥18岁)ICU患者并随访至ICU出院或28天,旨在描述ICU输血实践、站点间差异,并与国家指南及既往实践比较。结果显示927例患者中217例(23.4%)接受输血,其中红细胞192例(20.7%)、血小板63例(6.8%)、新鲜冰冻血浆49例(5.3%)、冷沉淀29例(3.1%)。与国家指南相比,红细胞输血89.0%符合,血小板30.3%、新鲜冰冻血浆27.4%、冷沉淀20.0%符合。与2008年实践相比,调整混杂因素后,接受红细胞和新鲜冰冻血浆的患者每人输注单位数更多,且红细胞、血小板和新鲜冰冻血浆的总输血站点间变异增加。结论认为ICU输血常见但实践异质且常与指南不一致,每患者输注单位数增加,需要更多证据。
要点
- 927例成人ICU患者中217例(23.4%)接受输血,红细胞192例(20.7%)、血小板63例(6.8%)、新鲜冰冻血浆49例(5.3%)、冷沉淀29例(3.1%)。
- 与国家指南相比,红细胞输血89.0%符合,血小板30.3%符合,新鲜冰冻血浆27.4%符合,冷沉淀20.0%符合。
- 大规模输血方案在6例患者中实施了9次(0.7%)。
- 268次非红细胞输血中,25次(9.3%)使用了粘弹性止血试验(VHA)。
- 与2008年ICU输血实践相比,调整混杂因素后,接受红细胞和新鲜冰冻血浆的患者每人输注单位数更多,红细胞、血小板和新鲜冰冻血浆的总输血站点间变异增加。
适用人群与场景
- 澳大利亚和新西兰40个ICU中所有成人(≥18岁)ICU患者,纳入时间为2021年10月至2022年7月期间一周内入院者,随访至ICU出院或28天。
研究设计与关键结果
- 研究类型:前瞻性、多中心、双国观察性研究,纳入40个澳大利亚和新西兰ICU,共927例成人(≥18岁)ICU患者。
- 主要终点:217例(23.4%)接受输血,其中红细胞192例(20.7%)、血小板63例(6.8%)、新鲜冰冻血浆49例(5.3%)、冷沉淀29例(3.1%);大规模输血方案在6例患者中实施9次(0.7%)。
- 与非红细胞输血相关:268次非红细胞输血中,25次(9.3%)使用了粘弹性止血试验(VHA)。
- 与国家指南一致性:红细胞输血89.0%符合,血小板30.3%符合,新鲜冰冻血浆27.4%符合,冷沉淀20.0%符合。
- 与2008年ICU输血实践比较:调整混杂变量后,接受红细胞和新鲜冰冻血浆的患者每人输注单位数更多,红细胞、血小板和新鲜冰冻血浆的总输血站点间变异增加。
证据类型、等级与局限
- 证据类型:前瞻性、多中心、双国观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Blood transfusions are a common and potentially lifesaving intervention in ICU patients but are associated with harm and often transfused inconsistently with guidelines. However, it is not well known how ICU transfusion practice has recently changed and if there is variation in transfusion practice.
OBJECTIVES: To describe blood transfusion practices in ICU, the variation in practice across sites, and to compare transfusion practices against national guidelines and with prior published practice.
DESIGN, SETTING, AND PARTICIPANTS: A prospective, multicenter, binational, observational study conducted in 40 Australian and New Zealand ICUs from October 2021 to July 2022. All adult (≥ 18 yr) ICU patients admitted over 1 week were included and followed until ICU discharge or 28 days.
MAIN OUTCOMES AND MEASURES: Types of transfusion, thresholds and reasons for transfusions, the use of viscoelastic hemostatic assays (VHAs), variation in transfusion practice across sites, and changes in transfusion practice over time.
RESULTS: Of 927 patients, 217 (23.4%) received a blood transfusion during their ICU admission-192 (20.7%) received RBCs, 63 (6.8%) received platelets, 49 (5.3%) received fresh frozen plasma (FFP), and 29 (3.1%) received cryoprecipitate. Massive transfusion protocols were implemented nine times for six patients (0.7%). VHA were used in 25 of 268 (9.3%) non-RBC transfusions. Compared with national guidelines, 89.0% of RBC transfusions, 30.3% of platelet, 27.4% of FFP, and 20.0% of cryoprecipitate transfusions were consistent. Compared with ICU transfusion practices in 2008, after adjusting for confounding variables, ICU patients who received RBC and FFP were transfused more units each, and variation in total transfusions across sites increased for RBC, platelets, and FFP.
CONCLUSIONS AND RELEVANCE: Blood transfusions are common in ICU, but the practice is heterogeneous and frequently inconsistent with national guidelines, and the number of units transfused per patient has increased. More evidence is required.
参考来源
- Flint AWJ, Poole A, Raasveld SJ, et al. Blood Transfusion Practices in Intensive Care: A Prospective Observational Binational Study. Crit Care Explor. 2025. PMID: 39982126. doi:10.1097/CCE.0000000000001197
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。